$Nuvation Bio (NUVB.US)$Reuters· just1min U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced Ros1-Positive Non-Small Cell Lung Cancer! June 23, 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more